Episode 78: Pharma existentialism, mainstreaming cyborgs, & FDA palace intrigue
This episode isn’t summarized yet
Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.
Show notes
What separates good drug companies from mediocre ones? Have biohackers sold out? And who's going to run the FDA?